Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamases producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa)